Stanley Kugler

555 total citations
12 papers, 373 citations indexed

About

Stanley Kugler is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Stanley Kugler has authored 12 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Cancer Research. Recurrent topics in Stanley Kugler's work include Melanoma and MAPK Pathways (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Quinazolinone synthesis and applications (3 papers). Stanley Kugler is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Quinazolinone synthesis and applications (3 papers). Stanley Kugler collaborates with scholars based in United States, France and Japan. Stanley Kugler's co-authors include Mohammed A. Kashem, Roger J. Snow, Scott Jakes, Paul V. Kaplita, A. Wayne, Di Wu, Charles A. Kennedy, Revati J. Tatake, Erick R. R. Young and Eugene R. Hickey and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Stanley Kugler

12 papers receiving 364 citations

Peers

Stanley Kugler
D.J. Marcotte United States
Lori K. Gavrin United States
James R. Porter United States
Rich Woessner United States
Amy M. Delaney United States
Junping Pei China
John P. Wolak United States
Edward J. Lewis United Kingdom
Nicolas Warin United Kingdom
Tyler S. Beyett United States
D.J. Marcotte United States
Stanley Kugler
Citations per year, relative to Stanley Kugler Stanley Kugler (= 1×) peers D.J. Marcotte

Countries citing papers authored by Stanley Kugler

Since Specialization
Citations

This map shows the geographic impact of Stanley Kugler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley Kugler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley Kugler more than expected).

Fields of papers citing papers by Stanley Kugler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley Kugler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley Kugler. The network helps show where Stanley Kugler may publish in the future.

Co-authorship network of co-authors of Stanley Kugler

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley Kugler. A scholar is included among the top collaborators of Stanley Kugler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley Kugler. Stanley Kugler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Weldon, Steven M., Derek A. Cogan, Matthew A. Cerny, et al.. (2025). Pharmacodynamic effects of highly selective aldosterone synthase inhibitor vicadrostat in cynomolgus monkeys: Contrasting effects of once versus twice daily dosing. Journal of Pharmacology and Experimental Therapeutics. 392(8). 103649–103649. 1 indexed citations
2.
Anderson, Marie, Delphine Collin, Ingo Muegge, et al.. (2017). Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors. Journal of Biological Chemistry. 292(28). 11618–11630. 42 indexed citations
3.
Muegge, Ingo, Delphine Collin, B. Cook, et al.. (2015). Discovery of 1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxide analogs as new RORC modulators. Bioorganic & Medicinal Chemistry Letters. 25(9). 1892–1895. 18 indexed citations
4.
Burke, Jennifer, Xin Guo, Roger J. Snow, et al.. (2011). Indole RSK inhibitors. Part 1: Discovery and initial SAR. Bioorganic & Medicinal Chemistry Letters. 22(1). 733–737. 25 indexed citations
5.
Burke, Jennifer, Xin Guo, Roger J. Snow, et al.. (2011). Indole RSK inhibitors. Part 2: Optimization of cell potency and kinase selectivity. Bioorganic & Medicinal Chemistry Letters. 22(1). 738–742. 30 indexed citations
6.
Wu, Frank, Frank Büttner, Eugene R. Hickey, et al.. (2010). Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account. Bioorganic & Medicinal Chemistry Letters. 20(11). 3235–3239. 15 indexed citations
7.
Bosanac, Todd, Eugene R. Hickey, John D. Ginn, et al.. (2010). Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: Part 3, aryl substituted pyrrolidines. Bioorganic & Medicinal Chemistry Letters. 20(12). 3746–3749. 40 indexed citations
8.
Ginn, John D., Todd Bosanac, Charles L. Cywin, et al.. (2010). Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: Part 2, optimization for blood pressure reduction in spontaneously hypertensive rats. Bioorganic & Medicinal Chemistry Letters. 20(17). 5153–5156. 20 indexed citations
9.
Morwick, Tina M., Frank Büttner, Charles L. Cywin, et al.. (2009). Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase. Journal of Medicinal Chemistry. 53(2). 759–777. 8 indexed citations
10.
Bentzien, Jörg, Steven S. Pullen, Joseph R. Woska, et al.. (2008). 2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocket. Bioorganic & Medicinal Chemistry Letters. 18(23). 6218–6221. 18 indexed citations
11.
Cook, Brian N., Jörg Bentzien, André White, et al.. (2008). Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design. Bioorganic & Medicinal Chemistry Letters. 19(3). 773–777. 29 indexed citations
12.
Tatake, Revati J., Charles A. Kennedy, A. Wayne, et al.. (2008). Identification of pharmacological inhibitors of the MEK5/ERK5 pathway. Biochemical and Biophysical Research Communications. 377(1). 120–125. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D.J. Marcotte Breakdown of academic impact, for papers by Lori K. Gavrin Breakdown of academic impact, for papers by James R. Porter Breakdown of academic impact, for papers by Rich Woessner Breakdown of academic impact, for papers by Amy M. Delaney Breakdown of academic impact, for papers by Junping Pei Breakdown of academic impact, for papers by John P. Wolak Breakdown of academic impact, for papers by Edward J. Lewis Breakdown of academic impact, for papers by Nicolas Warin Breakdown of academic impact, for papers by Tyler S. Beyett
Rankless by CCL
2026